Establishment and characterization of two human cutaneous angiosarcoma cell lines, KU-CAS3 and KU-CAS5
- Authors
- You, Hi-Jin; Kim, Hyung-Kyu; Kim, Min-Sook; Lee, Yun-Hwan; Chung, Jae-Ho; Hwang, Na-Hyun; Kim, Deok-Woo; Choi, Jung-Woo; Lee, Ju-Han
- Issue Date
- 1월-2022
- Publisher
- WILEY
- Keywords
- cell line; cutaneous angiosarcoma; tumorigenesis
- Citation
- HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, v.44, no.1, pp.7 - 17
- Indexed
- SCIE
SCOPUS
- Journal Title
- HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Volume
- 44
- Number
- 1
- Start Page
- 7
- End Page
- 17
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/135306
- DOI
- 10.1002/hed.26886
- ISSN
- 1043-3074
- Abstract
- Background Cutaneous angiosarcoma (CAS) is a rare but fatal cancer. Established CAS cell lines are necessary for the investigation of their properties and treatment options. Methods Two cell lines, KU-CAS3 and KU-CAS5, were established from human angiosarcoma specimens obtained from the scalp. Flow cytometric assay, tube formation assay, low-density lipoprotein (LDL) uptake assay, immunofluorescence analysis, real-time PCR, tumorigenesis assay, and STR analysis were conducted. Results The cells showed endothelial cell properties, based on the cobblestone appearance upon reaching confluence, CD31 positivity, tube-formation activity, active uptake of acetylated LDL, and vWF expression. The two cell lines expressed relatively high levels of adrenergic beta 2 receptor, and the VEGF1 and VEGF2 receptors. In the in vivo study, the growing neoplasms, confirmed as CAS, were identified as subcutaneous dark papules. KU-CAS cell lines were considered authentic based on STR profiling. Conclusions KU-CAS3 and KU-CAS5 are the first human CAS cell lines having tumorigenic potential in vivo.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.